Yi‐An Bi
Pfizer (United States)(US)
Publications by Year
Research Areas
Drug Transport and Resistance Mechanisms, Pharmacogenetics and Drug Metabolism, Pharmacological Effects and Toxicity Studies, Liver Disease Diagnosis and Treatment, Metabolism and Genetic Disorders
Most-Cited Works
- → Use of Cryopreserved Human Hepatocytes in Sandwich Culture to Measure Hepatobiliary Transport(2006)212 cited
- → Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design(2012)152 cited
- → A Novel Relay Method for Determining Low-Clearance Values(2012)109 cited
- → Characterization of Organic Anion Transporting Polypeptide (OATP) Expression and Its Functional Contribution to the Uptake of Substrates in Human Hepatocytes(2012)104 cited
- → Quantitative assessment of the contribution of sodium‐dependent taurocholate co‐transporting polypeptide (NTCP) to the hepatic uptake of rosuvastatin, pitavastatin and fluvastatin(2013)83 cited
- → Quantitative Expression Profile of Hepatobiliary Transporters in Sandwich Cultured Rat and Human Hepatocytes(2009)81 cited
- → Role of Hepatic Transporters in the Disposition and Hepatotoxicity of a HER2 Tyrosine Kinase Inhibitor CP-724,714(2009)79 cited
- → Quantitative Contribution of Six Major Transporters to the Hepatic Uptake of Drugs: “SLC-Phenotyping” Using Primary Human Hepatocytes(2019)78 cited
- → Culture Period-Dependent Changes in the Uptake of Transporter Substrates in Sandwich-Cultured Rat and Human Hepatocytes(2011)73 cited
- → Quantitative Rationalization of Gemfibrozil Drug Interactions: Consideration of Transporters-Enzyme Interplay and the Role of Circulating Metabolite Gemfibrozil 1-O-β-Glucuronide(2015)69 cited